Advisory Committee on Breast Cancer in Young Women (ACBCYW); Notice of Charter Renewal, 43841 [2020-15616]
Download as PDF
<![CDATA[
43841
Federal Register / Vol. 85, No. 139 / Monday, July 20, 2020 / Notices
completion of the SAF, their requests
for approval are evaluated. A total of
375 applications were submitted in
CY2019. To date, 300 applications have
been submitted in CY2020. The
increased submission rate is due to the
publication of a new respirator class,
PAPR100, as well certification requests
due to COVID–19. No survey was
conducted to more thoroughly analyze
the reasons for the change in number of
respondents. The applications are
submitted at will, and taking into
account both historical conditions, as
well as the current situation, our
prediction of the number of respondents
each year between CY2020 and CY2022
is 140. A $200 fee is required for each
application. Respondents requesting
respirator approval or certain extensions
of approval are required to submit
standards, it is not expected that
requiring approved quality standards
will impose an additional cost burden
over similarly effective quality
standards that are not approved under
42 CFR part 84.
Manufacturers with current approvals
are subject to site audits by the Institute
or its agents. Audits may occur
periodically, typically every second
year, or as a result of a reported issue.
Sixty-four site audits from 90 respirator
approval holders were scheduled for the
2020 fiscal year. There is an average fee
of $12,656 for each audit to align with
fee collection provisions of the
Independent Offices Appropriations Act
of 1952 (31 U.S.C. 9701), and OMB
Circular A–25 Revised. It is estimated
that the average over the next three
years (FY21–FY23) will be 70.
additional fees for necessary testing and
evaluation as specified in 42 CFR parts
84.20–22, 84.66, 84.258 and 84.1102.
Applicants are required to provide
test data that shows the manufacturer is
capable of ensuring the respirator is
capable of meeting the specified
requirements in 42 CFR part 84. The
requirement for submitted test data is
likely to be satisfied by standard testing
performed by the manufacturer, and is
not required to follow the relevant
NIOSH Standard Test Procedures. As
additional testing is not required,
providing proof that an adequate test
has been performed is limited to
providing existing paperwork.
42 CFR part 84 approvals offer
corroboration that approved respirators
are produced to certain quality
standards. Although 42 CFR part 84
Subpart E prescribes certain quality
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
Business or other for-profit ...............
140
4
229
128,240
Business or other for-profit ...............
Standard Application Form for the
Approval of Respirators.
Audit .................................................
70
1
24
1,680
Total ...........................................
..........................................................
........................
........................
........................
129,920
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–15658 Filed 7–17–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Breast Cancer
in Young Women (ACBCYW); Notice of
Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter renewal.
AGENCY:
This gives notice under the
Federal Advisory Committee Act of
October 6, 1972, that the Advisory
Committee on Breast Cancer in Young
Women (ACBCYW), Centers for Disease
Control and Prevention, Department of
Health and Human Services, has been
renewed for a 2-year period through
June 17, 2022.
FOR FURTHER INFORMATION CONTACT:
Jeremy McCallister, Designated Federal
SUMMARY:
VerDate Sep<11>2014
18:30 Jul 17, 2020
Jkt 250001
Officer, National Center for Chronic
Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway
NE, Mailstop S107–4, Atlanta, Georgia
30341, Telephone (404) 639–7989, Fax
(770) 488–4760; Email: acbcyw@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–15616 Filed 7–17–20; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0083]
Advisory Committee on Immunization
Practices (ACIP)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC, announces the following meeting
of the Advisory Committee on
Immunization Practices (ACIP). This
meeting is open to the public. Time will
be available for public comment. The
meeting will be webcast live via the
World Wide Web.
DATES: The meeting will be held on
August 26, 2020 from 10:00 a.m. to 4:00
p.m., EDT (times subject to change).
Written comments must be received
on or before August 27, 2020.
ADDRESSES: For more information on
ACIP please visit the ACIP website:
SUMMARY:
E:\FR\FM\20JYN1.SGM
20JYN1
]]>Agencies
[Federal Register Volume 85, Number 139 (Monday, July 20, 2020)]
[Notices]
[Page 43841]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15616]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Breast Cancer in Young Women (ACBCYW);
Notice of Charter Renewal
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of charter renewal.
-----------------------------------------------------------------------
SUMMARY: This gives notice under the Federal Advisory Committee Act of
October 6, 1972, that the Advisory Committee on Breast Cancer in Young
Women (ACBCYW), Centers for Disease Control and Prevention, Department
of Health and Human Services, has been renewed for a 2-year period
through June 17, 2022.
FOR FURTHER INFORMATION CONTACT: Jeremy McCallister, Designated Federal
Officer, National Center for Chronic Disease Prevention and Health
Promotion, CDC, 4770 Buford Highway NE, Mailstop S107-4, Atlanta,
Georgia 30341, Telephone (404) 639-7989, Fax (770) 488-4760; Email:
[email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-15616 Filed 7-17-20; 8:45 am]
BILLING CODE 4163-18-P
